Semaglutide, liraglutide, and tirzepatide are all categorized as GLP-1 receptor agonists, meaning that they mimic the action of the GLP-1 hormone, which stimulates insulin. In mimicking the ...

For details, see the “What should be considered before taking Victoza?” section. Diabetes affects your metabolism. It causes high blood sugar due to problems making or using insulin in your body.

This study provides valuable guidance for doctors and patients when choosing diabetes medications. It confirms that ...

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

This launch follows the nod from the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA), making Biocon the first generics company to receive approval for Liraglutide in a major ...

Novo Nordisk’s GLP-1 agonist Victoza has become the first non-insulin drug to be approved in the US as a treatment for type 2 diabetes in children for almost two decades.

A new study suggests that medications commonly used for diabetes, including the popular drug Ozempic, may help reduce the ...

"The action of liraglutide in patients with type 2 diabetes is largely due to an increase in insulin secretion from the pancreas,," Dandona explains, "But since type 1 diabetics have no insulin ...

Liraglutide in United Kingdom: Our Bureau, Bengaluru Friday, February 28, 2025, 15:30 Hrs [IST] Biocon Limited, an innovation-led global ...